The short version of vaccine adjuvant fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-09. Anything still debated is marked as such rather than presented as settled.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.
The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
"Impact of elevated CO2 on shellfish calcification". Geophysical Research Letters. 34 (7): L07603. Bibcode:2007GeoRL..34.7603G. doi:10.1029/2006GL028554. hdl:20.500.11755/a8941c6a-6d0b-43d5-ba0d-157a7aa05668. Gattuso, J.-P.; Hansson, L.; "Ocean acidification" (Oxford University Press) Kroeker, K.; Kordas, R.; Crim, R.; Hendriks, I.; Ramajo, L.; Singh, G.; Duarte, C.; Gattuso, J.-P. (2013). "Impacts of ocean acidification on marine organisms: quantifying sensitivities and interaction with warming". Global Change Biology. 19 (6): 1884–1896. Bibcode:2013GCBio..19.1884K. doi:10.1111/gcb.12179. PMC 3664023. PMID 23505245. Gattuso, J.-P.; Magnan, A.; Billé, R.; Cheung, W.W.L.; Howes, E.L.; Joos, F.; Allemand, D.; Bopp, L.; Cooley, S.; Eakin, C.M.; Hoegh-Guldberg, O.; Kelly, R.P.; Pörtner, H.; Rogers, A.D.; Baxte, J.M.; Laffoley, D.; Osborn, D.; Rankovic, A.; Rochette, J.; Sumaila, U. R.; Treyer, S.; Turley, C. (2015). "Contrasting futures for ocean and society from different anthropogenic CO2 emissions scenarios" (PDF). Science. 349 (6243) aac4722. doi:10.1126/science.aac4722. PMID 26138982. S2CID 206639157. Magnan, A.K.; Colombier, M.; Billé, R.; Hoegh-Guldberg, O.; Joos, F.; Pörtner, H.-O; Waisman, H.; Spencer, T.; Gattuso, J.-P. (2016). "Implications of the Paris Agreement for the ocean". Nature Climate Change. 6 (8): 732–735. Bibcode:2016NatCC...6..732M. doi:10.1038/nclimate3038. Gattuso, J.-P.; Williamson, P.; Duarte, C.; Magnan, A.K. (2021). "The potential for ocean-based climate action: negative emissions technologies and beyond". Frontiers in Climate. 2 575716.
christyi had murine intraperitoneal LD50 of 0.052 and 0.083 mg/kg, respectively, and showed over 80% homology with N. nigricollis alpha toxin. Reverse-phase analysis of another peak present in both venoms resolved a toxin that had an N-terminus identical to N. christyi short-chain neurotoxin 1. These fractions also contained toxins readily separable from the short-chain isotoxin by preparative reverse-phase chromatography. Amino acid sequencing of the first 28 residues indicated that both toxins were long-chain neurotoxins with identical N-termini. The LD50 of long-chain neurotoxins 2 from N. a. annulata and N. christyi venoms were 0.086 and 0.090 mg/kg, respectively. The venoms of these little-known elapids have the lowest intraperitoneal LD50 of any African Naja species studied thus far and have high concentrations of potent postsynaptic neurotoxins.
=== Radiation protection register === According to § 170 StrlSchG [Radiation Protection Act] (in German) all occupationally exposed persons and holders of radiation passports require a radiation protection register number (SSR number or SSRN), a unique personal identification number, as of December 31, 2018. The SSR number facilitates and improves the allocation and balancing of individual dose values from occupational radiation exposure in the radiation protection register. It replaces the former radiation passport number. It is used to monitor dose limits. Companies are obliged to deploy their employees in such a way that the radiation dose to which they are exposed does not exceed the limit of 20 millisieverts per calendar year. In Germany, about 440,000 people were classified as occupationally exposed to radiation in 2016. According to § 145 StrlSchG [German Radiation Protection Act] (in German) paragraph 1, Sentence 1, "in the case of remediation and other measures to prevent and reduce exposure at radioactively contaminated sites, the person who carries out the measures himself or has them carried out by workers under his supervision must carry out an assessment of the body dose of the workers before starting the measures". Applications for SSR numbers must be submitted to the Federal Office for Radiation Protection (BfS) by March 31, 2019 for all employees currently under surveillance.
=== Receptors === Innate immune system senses intact peptidoglycan and peptidoglycan fragments using numerous PRRs (pattern recognition receptors) that are secreted, expressed intracellularly or expressed on the cell surface.
Sources: en.wikipedia.org
Collagen alpha-1 (XXVII) chain (COL27A1) is a protein that in humans is encoded by the COL27A1 gene. COL27A1 is a type XXVII collagen. It was discovered by James Pace. This gene appears to be turned on in cartilage, the eye, and in the ear. Type XXVII collagen is related to the "fibrillar" class of collagens and may play a role in development of the skeleton. Fibrillar collagens, such as COL27A1, compose one of the most ancient families of extracellular matrix molecules. They form major structural elements in extracellular matrices of cartilage, skin, and tendon.
Alginate biopolymer applications range from packaging, textile and food industry to biomedical and chemical engineering. The first ever application of alginate was in the form of wound dressing, where its gel-like and absorbent properties were discovered. When applied to wounds, alginate produces a protective gel layer that is optimal for healing and tissue regeneration, and keeps a stable temperature environment. Additionally, there have been developments with alginate as a drug delivery medium, as drug release rate can easily be manipulated due to a variety of alginate densities and fibrous composition.
Monoclonal antibodies that can be used to block pro-inflammatory cytokines Antigen-specific immunotherapy which allows immune cells to specifically target the abnormal cells that cause autoimmune disease Co-stimulatory blockade that works to block the pathway that leads to the autoimmune response Regulatory T cell therapy that utilizes this special type of T cell to suppress the autoimmune response Thymoquinone, a compound found in the flower Nigella sativa, has been studied for potential in treating several autoimmune diseases due to its effects on inflammation.
The latest generation of radioluminescent materials is based on tritium, a radioactive isotope of hydrogen with half-life of 12.32 years that emits very low-energy beta radiation. It is used on wristwatch faces, gun sights, and emergency exit signs. The tritium gas is contained in a small glass tube, coated with a phosphor on the inside. Beta particles emitted by the tritium strike the phosphor coating and cause it to fluoresce, emitting light, usually yellow-green. Tritium is used because it is believed to pose a negligible threat to human health, in contrast to the previous radioluminescent source, radium, which proved to be a significant radiological hazard. The low-energy 5.7 keV beta particles emitted by tritium cannot pass through the enclosing glass tube. Even if they could, they are not able to penetrate human skin. Tritium is only a health threat if ingested or inhaled. Since tritium is a gas, if a tritium tube breaks, the gas dissipates in the air and is diluted to safe concentrations. Tritium has a half-life of 12.32 years, so the brightness of a tritium light source will decline to half its initial value in that time.
Alpha-glucosidase inhibitors (AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). Naturally occurring AGIs are found in raw plants/herbs such as cinnamon and white mulberry as well as some bacteria. Carbohydrates are normally converted into simple sugars (monosaccharides) by alpha-glucosidase enzymes present on cells lining the intestine, enabling monosaccharides to be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of dietary carbohydrates on blood sugar.
Sources: en.wikipedia.org
Very high product yields are usually accomplished without the formation of by-products or the synthesis of cell mass. For example, with a synthetic enzyme pathway, from the reaction with starch and water C6H10O5 (l) + 7 H2O (l) → 12 H2 (g) + 6 CO2 (g), nearly 12 H2 has been produced per glucose unit of polysaccharides and water, three times of the theoretical yield of the best anaerobic hydrogen-producing microorganisms. In vitro biosystems can implement some biological reactions that living microbes or chemical catalysts cannot implement before. For example, beta-1,4-glucosidic bond linked cellulose can be converted to alpha-1,4-glucosidic bond linked starch by a mixture of intracellular and extracellular enzymes in a single reaction container. Enzymatic systems, without the barrier of cellular membrane, usually have faster reaction rates than microbial systems. For instance, enzymatic fuel cells usually have much higher power outputs than microbial fuel cells. Enzyme cocktails can tolerate toxic compounds better than microorganisms. Enzyme mixtures usually work under broad reaction conditions, such as high temperature, low pH, the presence of organic solvents or ionic liquids.
There are 25 known isotopes of potassium, three of which occur naturally: 39K (93.3%), 40K (0.0117%), and 41K (6.7%) (by mole fraction). Naturally occurring 40K has a half-life of 1.250×109 years. It decays to stable 40Ar by electron capture or positron emission (11.2%) or to stable 40Ca by beta decay (88.8%). This decay results in a relatively higher concentration of Argon in the atmosphere. The decay of 40K to 40Ar is the basis of a common method for dating rocks. The conventional potassium–argon dating method depends on the assumption that the rocks contained no argon at the time of formation and that all the subsequent radiogenic argon (40Ar) was quantitatively retained. Minerals are dated by measurement of the concentration of potassium and the amount of radiogenic 40Ar that has accumulated. The minerals best suited for dating include biotite, muscovite, metamorphic hornblende, and volcanic feldspar; whole rock samples from volcanic flows and shallow instrusives can also be dated if they are unaltered. Apart from dating, potassium isotopes have been used as tracers in studies of weathering and for nutrient cycling studies because potassium is a macronutrient required for life on Earth. 40K occurs in natural potassium (and thus in some commercial salt substitutes) in sufficient quantity that large bags of those substitutes can be used as a radioactive source for classroom demonstrations. 40K is the radioisotope with the largest abundance in the human body. In healthy animals and people, 40K represents the largest source of radioactivity, greater even than 14C.
Stress and physical inactivity and alcohol reduce hepatalin secretion. In pregnancy, the role of hepatalin changes throughout the period of gestation. Hepatalin action predominates in the first trimester of gestation when uterine and fetal protein metabolism is required. Insulin action predominates in the third trimester when maternal and fetal fat stores are needed. Alcohol consumption during pregnancy results in dose-related suppression of hepatalin secretion in the adult offspring. Hepatalin can be acutely turned off and on by manipulation of the mechanisms (i.e., the three necessary signals) regulating hepatalin secretion.
== Mechanism == The formulation reported in a 2013 paper by Niewoehner et al. used a single-chain Fab fragment of a monoclonal antibody against the transferrin receptor, which normally mediates transcytosis of a 76 kDa glycoprotein across the blood–brain barrier. Epitope mapping of the anti-TfR antibody showed that the Brain Shuttle module binds at the apical domain of TfR, which is distant to the binding site of transferrin. This anti-TfR fragment was fused to the Fc region at the C-terminal end of either one or both of the heavy chains of an anti-amyloid beta antibody, mAb31. The version with two anti-TfR fragments had higher affinity to TfR than the single form but the two-fragment version was sorted to lysosomes and disappeared. The single form was successfully transported into the CNS compartment and rapidly attached to plaques in the brain, reaching maximum coverage at 8 hours after injection compared to 7 days for the original mAb31. The double form did not reach the plaques even at a high dose (17.44 mg/kg), whereas the single form showed a significant reduction in plaque numbers over mAb31 both in cortex and hippocampus at the middose of 2.67 mg/kg, and a smaller reduction at the low dose of 0.53 mg/kg.
== Biochemical context == Most are accompanied by α-ketoglutarate α-decarboxylation caused by dehydrogenation of hydroxyl carboxylic acids such as carbonyl carboxylic malic acid, isocitric acid, etc. Pyruvate is susceptible to oxidative decarboxylation to deliver the equivalent of the acetyl anion:
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.